Annexin A2 as a differential diagnostic marker of hepatocellular tumors

Pathology Research and Practice

Volumn 207, Issue 1, 2011, Pages 8-14

  Longerich, Thomas ^a   Haller, Maria Theresia ^a   Mogler, Carolin ^a   Aulmann, Sebastian ^a   Lohmann, Volker ^a   Schirmacher, Peter ^a   Brand, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

ANXA2; GPC3; GS; Hepatocellular carcinoma; HSP70

Indexed keywords

HEAT SHOCK PROTEIN 70; LIPOCORTIN 2; PHOSPHOLIPID BINDING PROTEIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MALIGNANT TRANSFORMATION; NEEDLE BIOPSY; PROTEIN EXPRESSION; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A2; BIOPSY; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUTAMATE-AMMONIA LIGASE; GLYPICANS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 78650236702     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.09.007     Document Type: Article

References (33)

1. Baumhoer D., Tornillo L., Stadlmann S., Roncalli M., Diamantis E.K., Terracciano L.M. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am. J. Clin. Pathol. 2008, 129:899-906.
2. Bioulac-Sage P., Laumonier H., Rullier A., Cubel G., Laurent C., Zucman-Rossi J., Balabaud C. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int. 2009, 29:459-465.
3. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J.F., Saric J., Sa Cunha A., Rullier A., Cubel G., Couchy G., Imbeaud S., Balabaud C., Zucman-Rossi J. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007, 46:740-748.
4. Bolondi L., Gaiani S., Celli N., Golfieri R., Grigioni W.F., Leoni S., Venturi A.M., Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
5. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., Rodes J. Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001, 35:421-430.
6. Capurro M., Wanless I.R., Sherman M., Deboer G., Shi W., Miyoshi E., Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003, 125:89-97.
7. Chetcuti A., Margan S.H., Russell P., Mann S., Millar D.S., Clark S.J., Rogers J., Handelsman D.J., Dong Q. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res. 2001, 61:6331-6334.
8. Coston W.M., Loera S., Lau S.K., Ishizawa S., Jiang Z., Wu C.L., Yen Y., Weiss L.M., Chu P.G. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry. Am. J. Surg. Pathol. 2008, 32:433-444.
9. Di Tommaso L., Destro A., Seok J.Y., Balladore E., Terracciano L., Sangiovanni A., Iavarone M., Colombo M., Jang J.J., Yu E., Jin S.Y., Morenghi E., Park Y.N., Roncalli M. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J. Hepatol. 2009, 50:746-754.
10. Di Tommaso L., Franchi G., Park Y.N., Fiamengo B., Destro A., Morenghi E., Montorsi M., Torzilli G., Tommasini M., Terracciano L., Tornillo L., Vecchione R., Roncalli M. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
11. Emoto K., Sawada H., Yamada Y., Fujimoto H., Takahama Y., Ueno M., Takayama T., Uchida H., Kamada K., Naito A., Hirao S., Nakajima Y. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 2001, 21:1339-1345.
12. Erikson E., Erikson R.L. Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product. Cell 1980, 21:829-836.
13. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 2002, 82:331-371.
14. Ishak K.G., Goodman Z.D., Zachary D., Thomas S.J. Tumors of the Liver and Intrahepatic Bile Ducts 2001, Series III:199-230. AFIP Atlas of Tumor Pathology, Washington.
15. Ji N.Y., Park M.Y., Kang Y.H., Lee C.I., Kim D.G., Yeom Y.I., Jang Y.J., Myung P.K., Kim J.W., Lee H.G., Lee K., Song E.Y. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int. J. Mol. Med. 2009, 24:765-771.
16. Kojiro M., Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin. Liver Dis. 2005, 25:133-142.
17. Libbrecht L., Severi T., Cassiman D., Vander Borght S., Pirenne J., Nevens F., Verslype C., Van Pelt J., Roskams T. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am. J. Surg. Pathol. 2006, 30:1405-1411.
18. Longerich T., Breuhahn K., Odenthal M., Petmecky K., Schirmacher P. Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma. Virchows Arch. 2004, 445:589-596.
19. Masaki T., Tokuda M., Fujimura T., Ohnishi M., Tai Y., Miyamoto K., Itano T., Matsui H., Watanabe S., Sogawa K., et al. Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes?. Hepatology 1994, 20:425-435.
20. Mohammad H.S, Kurokohchi K., Yoneyama H., Tokuda M., Morishita A., Jian G., Shi L., Murota M., Tani J., Kato K., Miyoshi H., Deguchi A., Himoto T., Usuki H., Wakabayashi H., Izuishi K., Suzuki Y., Iwama H., Deguchi K., Uchida N., Sabet E.A., Arafa U.A., Hassan A.T., El-Sayed A.A., Masaki T. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 2008, 33:1157-1163.
21. International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009, 49:658-664.
22. Paciucci R., Tora M., Diaz V.M., Real F.X. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 1998, 16:625-633.
23. Park Y.N., Yang C.P., Fernandez G.J., Cubukcu O., Thung S.N., Theise N.D. Neoangiogenesis and sinusoidal " capillarization" in dysplastic nodules of the liver. Am. J. Surg. Pathol. 1998, 22:656-662.
24. Pena-Alonso E., Rodrigo J.P., Parra I.C., Pedrero J.M., Meana M.V., Nieto C.S., Fresno M.F., Morgan R.O., Fernandez M.P. Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett. 2008, 263:89-98.
25. Remmele W., Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987, 8:138-140.
26. Roncalli M., Roz E., Coggi G., Di Rocco M.G., Bossi P., Minola E., Gambacorta M., Borzio M. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999, 30:1174-1178.
27. Singh P. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett. 2007, 252:19-35.
28. Thiel C., Osborn M., Gerke V. The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J. Cell Sci. 1992, 103(Pt 3):733-742.
29. Tomonaga T., Matsushita K., Yamaguchi S., Oh-Ishi M., Kodera Y., Maeda T., Shimada H., Ochiai T., Nomura F. Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin. Cancer Res. 2004, 10:2007-2014.
30. Wang X.Y., Degos F., Dubois S., Tessiore S., Allegretta M., Guttmann R.D., Jothy S., Belghiti J., Bedossa P., Paradis V. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum. Pathol. 2006, 37:1435-1441.
31. Yoon S.Y., Kim J.M., Oh J.H., Jeon Y.J., Lee D.S., Kim J.H., Choi J.Y., Ahn B.M., Kim S., Yoo H.S., Kim Y.S., Kim N.S. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int. J. Oncol. 2006, 29:315-327.
32. Yu G.R., Kim S.H., Park S.H., Cui X.D., Xu D.Y., Yu H.C., Cho B.H., Yeom Y.I., Kim S.S., Kim S.B., Chu I.S., Kim D.G. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma. Exp. Mol. Med. 2007, 39:641-652.
33. Zucman-Rossi J., Jeannot E., Nhieu J.T., Scoazec J.Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E.S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006, 43:515-524.